Routes of
administration Oral | ||
 | ||
Legal status US: Analogue to a Schedule I/II drug (but only if it is intended for human consumption) | ||
IP-LAD, known also as 6-isopropyl-6-nor-lysergic acid diethylamide, is an analogue of LAD developed by the team of David E. Nicols. In studies on mice, it was found to be approximately 40% the potency of LAD, compared to the 60% increase in potency seen with ETH-LAD and roughly equivalent potency in AL-LAD and PRO-LAD.
References
6-Isopropyl-6-nor-lysergic acid diethylamide Wikipedia(Text) CC BY-SA